AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10972697
Drug: Epoetin alpha
RxNorm normalized name: Epoetin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epoetin alpha to achieve hemoglobin levels of 13.5 g/dL
Trial: 1474076
Drug: Low protein
RxNorm normalized name: Low protein mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low protein (LP) = 0.86 g protein.kg‐1.day‐1 for 13 days
Trial: 1474076
Drug: Moderate protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate protein (MP) = 1.40 g protein.kg‐1.day‐1 for 13 days
Trial: 1474076
Drug: High protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein (HP) = 2.40 g protein.kg‐1.day‐1 for 13 days
Trial: 21171135
Drug: Prolonged Exposure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged Exposure (PE) therapy
Trial: 26591355
Drug: Losartan Potassium
RxNorm normalized name: Losartan Potassium
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Losartan Potassium Tablet (50 mg once per day)
Trial: 18390837
Drug: Ofatumumab 300
RxNorm normalized name: Ofatumumab
DrugBank: Ofatumumab (DB06650)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ofatumumab 300 mg
Trial: 18390837
Drug: Ofatumumab 700
RxNorm normalized name: Ofatumumab
DrugBank: Ofatumumab (DB06650)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ofatumumab 700 mg
Trial: 30723894
Drug: Ofatumumab 1000
RxNorm normalized name: ofatumumab 1000 MG in 50 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofatumumab 1000 mg
Trial: 20506254
Drug: Ofatumumab (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofatumumab (all doses combined)
Trial: 18160461
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (25, 50, 125, 300, or 600 mg im) for 20 weeks
Trial: 17063637
Drug: Gliclazide modified
RxNorm normalized name: gliclazide
DrugBank: Gliclazide (DB01120)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gliclazide modified release (MR) tablets (30 mg)
Trial: 17063637
Drug: Commercial gliclazide
RxNorm normalized name: gliclazide
DrugBank: Gliclazide (DB01120)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial gliclazide standard preparation (30 mg)
Trial: 14628980
Drug: Aripiprazole 15
RxNorm normalized name: aripiprazole 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole 15 mg
Trial: 9243044
Drug: Isoniazid (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoniazid (300 mg/d)
Trial: 9243044
Drug: Rifampin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin (600 mg/d)
Trial: 9243044
Drug: Pyrazinamide (1,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyrazinamide (1,500 mg/d)
Trial: 8478235
Drug: Hyperthermia treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperthermia treatment (60 min, 1 or 2 times per week during irradiation)
Trial: 31564236
Drug: Outpatient physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient physical therapy intervention including a 1-hour initial assessment and individualized treatment plans
Trial: 22441448
Drug: Single injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single injection of 1 ml betamethasone and 1 ml prilocaine on the lateral epicondyle at the point of maximum tenderness.
Trial: 22441448
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of the same drug mixture with needle tip redirected and reinserted down the bone approximately 30 to 40 times without emerging from the skin, creating a hematoma.
Trial: 19933822
Drug: Cushing's syndrome
RxNorm normalized name: Mifepristone 300mg Oral tablet [Cushing's Syndrome Hyperglycemia]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cushing's syndrome treatment (normalization of corticosteroid excess)
Trial: 19933822
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment for Cushing's syndrome)
Trial: 16904718
Drug: CQ 50
RxNorm normalized name: Chloroquine 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CQ 50 mg/kg
Trial: 16904718
Drug: CQ 25
RxNorm normalized name: Chloroquine 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CQ 25 mg/kg
Trial: 16904718
Drug: AQ 15
RxNorm normalized name: Follistim AQ 150 UNT in 0.5 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AQ 15 mg/kg
Trial: 16904718
Drug: AQ 30
RxNorm normalized name: Follistim AQ 300 UNT in 0.36 ML Cartridge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AQ 30 mg/kg
Trial: 16168215
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist (group B)
Trial: 16168215
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (group A)
Trial: 11787985
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (50 mg zinc as gluconate, orally, for 12 weeks)
Trial: 28945160
Drug: Telemedicine-delivered behaviour
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telemedicine-delivered behaviour activation treatment (BAT)
Trial: 28945160
Drug: Same-room behaviour
RxNorm normalized name: SAMe
DrugBank: Ademetionine (DB00118)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Same-room behaviour activation treatment (BAT)
Trial: 27059816
Drug: Dulaglutide 1.5
RxNorm normalized name: dulaglutide 1.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dulaglutide 1.5 mg/week
Trial: 27059816
Drug: Dulaglutide 0.75
RxNorm normalized name: DULAGLUTIDE 0.75MG/0.5ML INJ PEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dulaglutide 0.75 mg/week
Trial: 27059816
Drug: Metformin ≥1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin ≥1500 mg/day
Trial: 24063860
Drug: sorafenib plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sorafenib plus interleukin-2 (IL-2) 400 mg twice daily plus subcutaneous IL-2 4.5 million international units (MIU) five times per week for 6 weeks every 8 weeks (arm A)
Trial: 21463474
Drug: Remoxy 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remoxy 40 mg whole (fed)
Trial: 21463474
Drug: Remoxy 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remoxy 40 mg chewed (fed)
Trial: 21463474
Drug: Oxycodone ER
RxNorm normalized name: oxycodone Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone ER 40 mg (crushed, fasted)
Trial: 21463474
Drug: Oxycodone IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone IR 40 mg (crushed, fasted)
Trial: 21463474
Drug: Oxycodone ER
RxNorm normalized name: oxycodone Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone ER 40 mg (whole and chewed)
Trial: 12927657
Drug: Amiloride (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiloride (10 mg daily)
Trial: 29290068
Drug: 0.5% minoxidil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% minoxidil cream applied twice daily for 2 weeks
Trial: 29290068
Drug: 2% diltiazem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% diltiazem cream applied twice daily for 2 weeks
Trial: 24239790
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (cathodal tDCS + VR)
Trial: 21974764
Drug: Valsartan 10-20
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Valsartan 10-20 mg
Trial: 21974764
Drug: Valsartan 80-160
RxNorm normalized name: valsartan 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 80-160 mg
Trial: 15668554
Drug: Conventional chest
RxNorm normalized name: Kids-Eeze Chest Relief
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional chest physical treatments
Trial: 9517989
Drug: Oral ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ganciclovir (GCV) 1000 mg three times/day
Trial: 9517989
Drug: Oral ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ganciclovir (GCV) 1000 mg three times/day (at protocol amendment)
Trial: 9517989
Drug: Oral ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ganciclovir (GCV) for patients taking didanosine (ddI)
Trial: 9517989
Drug: Oral ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ganciclovir (GCV) for patients not taking didanosine (ddI)
Trial: 3261547
Drug: Intravenous bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bolus injection in the antecubital fossa
Trial: 3261547
Drug: Intravenous propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous propofol mixed with lignocaine
Trial: 3261547
Drug: Slowing the
RxNorm normalized name: THE-630
DrugBank: THE-630 (DB16750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slowing the speed of injection
Trial: 24389403
Drug: 60 mL
RxNorm normalized name: Disposable Nurser 60 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mL of red wine
Trial: 24389403
Drug: 60 mL
RxNorm normalized name: Disposable Nurser 60 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mL of vodka
Trial: 18675399
Drug: High stress
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High stress (prior to receiving methadone dose)
Trial: 18675399
Drug: Low stress
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low stress (immediately following methadone dose)
Trial: 17186094
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose streptokinase (500,000 to 750,000 U)
Trial: 17186094
Drug: Classical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Classical therapy (1.5 million U)
Trial: 1680135
Drug: Low dosage
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dosage of zidovudine
Trial: 1680135
Drug: High dosage
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dosage of zidovudine
Trial: 6134543
Drug: lorazepam 3
RxNorm normalized name: lorazepam 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lorazepam 3 mg
Trial: 6134543
Drug: diazepam 15
RxNorm normalized name: diazepam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam 15 mg
Trial: 7793217
Drug: lorazepam 1
RxNorm normalized name: lorazepam 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lorazepam 1 mg
Trial: 30531464
Drug: Microdoses of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microdoses of recombinant human erythropoietin (rHuEpo) (20‐40 IUkg) administered twice per week for 7 weeks
Trial: 30531464
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered twice per week for 7 weeks
Trial: 18053628
Drug: Modafinil treatment
RxNorm normalized name: Modafinil
DrugBank: Modafinil (DB00745)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Modafinil treatment for 21 days
Trial: 18053628
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment for 21 days
Trial: 31273283
Drug: Modafinil treatment
RxNorm normalized name: Modafinil
DrugBank: Modafinil (DB00745)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Modafinil treatment
Trial: 15945001
Drug: Dorzolamide/Timolol fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dorzolamide/Timolol fixed combination (DTFC) 0.5%/2%
Trial: 15552533
Drug: Diet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet therapy with antihypertensive drugs (E1)
Trial: 15552533
Drug: Single diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single diet therapy (E2)
Trial: 9064058
Drug: Lomefloxacin 400
RxNorm normalized name: lomefloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lomefloxacin 400 mg once daily for 3 days
Trial: 9064058
Drug: Norfloxacin 800
RxNorm normalized name: Norfloxacin
DrugBank: Norfloxacin (DB01059)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norfloxacin 800 mg twice daily for 10 days
Trial: 8341188
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose salbutamol (2.5 mg)
Trial: 8341188
Drug: Variable dose
RxNorm normalized name: methohexital
DrugBank: Methohexital (DB00474)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Variable dose salbutamol (0.1 mg/kg bodyweight)
Trial: 8341188
Drug: Both preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both preparations of salbutamol
Trial: 3525883
Drug: S6472 (1,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S6472 (1,500 mg/day, 750 mg after breakfast and supper for 14 days)
Trial: 3525883
Drug: Cefaclor (CCL)
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor (CCL) (1,500 mg/day, 500 mg after every meal for 14 days)
Trial: 3525883
Drug: Amoxicillin (AMPC)
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin (AMPC) (2,000 mg/day, 500 mg after every meal and at bedtime for 14 days)
Trial: 28849779
Drug: Intravenous ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketamine (0.5 mg/kg over 40 min)
Trial: 25622633
Drug: Compound digestive
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound digestive enzyme tablet (Bearse) plus 2 analog capsules of compound digestive enzyme thrice daily
Trial: 25622633
Drug: Compound digestive
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound digestive enzyme capsule (Dages) plus 1 analog tablet of compound digestive enzyme thrice daily
Trial: 25622633
Drug: Compound digestive
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound digestive enzyme tablet (Bearse)
Trial: 25622633
Drug: Compound digestive
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound digestive enzyme capsule (Dages)
Trial: 23246119
Drug: Topical voriconazole
RxNorm normalized name: Voriconazole
DrugBank: Voriconazole (DB00582)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical voriconazole therapy (1% voriconazole)
Trial: 23246119
Drug: Intrastromal voriconazole
RxNorm normalized name: Voriconazole
DrugBank: Voriconazole (DB00582)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrastromal voriconazole (50 μg/0.1 ml)
Trial: 18837860
Drug: Quetiapine (400-800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (400-800 mg/day, twice daily)
Trial: 10096260
Drug: R-verapamil (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-verapamil (120 mg)
Trial: 497074
Drug: Extradural analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extradural analgesia (EA) with 50 or 100 mg of etidocaine without adrenaline in the supine position
Trial: 497074
Drug: Extradural analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extradural analgesia (EA) with 50 or 100 mg of etidocaine without adrenaline in the lateral position
Trial: 30387869
Drug: Single-implant mandibular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-implant mandibular overdenture (SIMO)
Trial: 30049849
Drug: Vasopressin V2
RxNorm normalized name: Vasopressin
DrugBank: Vasopressin (DB00067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vasopressin V2 receptor antagonists
Trial: 30049849
Drug: Disease-modifying treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease-modifying treatments (e.g., somatostatin analogs and other novel agents)
Trial: 19949136
Drug: Aspirin, 80
RxNorm normalized name: Non-Aspirin, 80 mg/0.8 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin, 80 mg/d for 8 weeks
Trial: 19034856
Drug: ATTENTIONER therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATTENTIONER therapy
Trial: 15733716
Drug: Normal hospital
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal hospital diet plus oral nutritional supplements
Trial: 14571284
Drug: Carbamazepine with
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine with honey (200 mg carbamazepine + 30 ml honey)
Trial: 14571284
Drug: Carbamazepine with
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine with water (200 mg carbamazepine + water)
Trial: 8618248
Drug: Extended relief
RxNorm normalized name: Midol Extended Relief
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extended relief acetaminophen
Trial: 8618248
Drug: Regular release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular release acetaminophen
Trial: 2340539
Drug: ORS‐90 (WHO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORS‐90 (WHO ORS) with sodium 90 mmol/L and glucose 111 mmol/L, osmolality 311 mosm/kg
Trial: 2340539
Drug: ORS‐60 with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORS‐60 with sodium 60 mmol/L and glucose 90 mmol/L, osmolality 240 mosm/kg
Trial: 7282615
Drug: Aspartame (34
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspartame (34 mg/kg body weight)
Trial: 7282615
Drug: Sucrose (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucrose (1 g/kg body weight)
Trial: 20473540
Drug: Pulsed electromagnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed electromagnetic field therapy (PEMF)
Trial: 6143039
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (after 8 weeks without treatment)
Trial: 27328752
Drug: Naltrexone/bupropion (NB)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone/bupropion (NB) 32/360 mg
Trial: 24251424
Drug: Nutritional supplement
RxNorm normalized name: Nutritional supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplement drinks served in a glass/beaker
Trial: 24251424
Drug: Nutritional supplement
RxNorm normalized name: Nutritional supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplement drinks served via straw
Trial: 20200540
Drug: Multinutrient supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multinutrient supplement providing increased protein and energy (P/E)
Trial: 17638495
Drug: Positive display
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Positive display rules (e.g., be enthusiastic and hide frustration)
Trial: 15947510
Drug: Exposure to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure to related and other cues followed by well-being therapy (WBT)
Trial: 7597439
Drug: Paclitaxel plus
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel plus carboplatin (doses escalated from 300 to 450 mg/m2 for carboplatin and 125 to 175 mg/m2 for paclitaxel)
Trial: 2113764
Drug: Transdermal nitroglycerin
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin (15 mg)
Trial: 30584782
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (CT; multimodal therapy plus aerobic training)
Trial: 27490162
Drug: Tiotropium Respimat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium Respimat 5 µg
Trial: 27490162
Drug: Tiotropium Respimat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium Respimat 2.5 µg
Trial: 27490162
Drug: HandiHaler 18
RxNorm normalized name: Spiriva HandiHaler 18 MCG Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HandiHaler 18 µg
Trial: 19197174
Drug: Couple-based interventions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Couple-based interventions that educate both partners about the woman's diagnosis and treatments, promote mutual coping and support, and include sexual therapy techniques.
Trial: 19197174
Drug: Interventions including
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interventions including sexual therapy techniques
Trial: 17084676
Drug: Vagus nerve
RxNorm normalized name: SUS SCROFA VAGUS NERVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vagus nerve stimulation (VNS) therapy
Trial: 17203016
Drug: VNS therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VNS therapy
Trial: 15206991
Drug: Terbogrel 150
RxNorm normalized name: Terbogrel
DrugBank: Terbogrel (DB12204)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbogrel 150 mg